Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature
F Lachenal, F Cotton, H Desmurs-Clavel, J Haroche… - Journal of …, 2006 - Springer
Erdheim-Chester disease (ECD) is a rare, non-Langerhans form of histiocytosis of unknown
etiology that affects multiple organs. We report 6 cases of ECD with neurological …
etiology that affects multiple organs. We report 6 cases of ECD with neurological …
Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients
F Lachenal, F Berger, H Ghesquières, P Biron, A Hot… - Medicine, 2007 - journals.lww.com
We retrospectively analyzed 77 patients with pathologically diagnosed angioimmunoblastic
T-cell lymphoma from a single city. There were 43 men and 34 women; the median age was …
T-cell lymphoma from a single city. There were 43 men and 34 women; the median age was …
Granulomatous myositis: a clinical study of thirteen cases
…, L Feasson, F Bouhour, J Ninet, F Lachenal… - Muscle & …, 2007 - Wiley Online Library
Granulomatous myositis (GM) is a rare condition that has generally been described in
association with sarcoidosis. In the absence of sarcoidosis or other underlying disease, a …
association with sarcoidosis. In the absence of sarcoidosis or other underlying disease, a …
[HTML][HTML] Treatment with hypomethylating agent 5-azacytidine induces sustained response in angioimmunoblastic T cell lymphomas
…, S Barbieux, A Marçais, O Tournilhac, F Lachenal… - Blood, 2016 - Elsevier
Abstract Treatment of relapsed/refractory peripheral T-cell lymphoma (R/R PTCL) remains an
unmet medical need, as treatment with polychemotherapy is associated with poor outcome…
unmet medical need, as treatment with polychemotherapy is associated with poor outcome…
[HTML][HTML] Characteristics, outcome and treatments with cranial pachymeningitis: a multicenter French retrospective study of 60 patients
…, F Lachenal, R Cevallos, R Roos-Weil, F Lhote… - Medicine, 2018 - journals.lww.com
… Mekinian, Arsene MD, PhD a,* ; Maisonobe, Lucas MD a ; Boukari, Latifatou MD b ;
Melenotte, Cléa MD c ; Terrier, Benjamin MD, PhD d,e ; Ayrignac, Xavier MD, PhD f ; …
Melenotte, Cléa MD c ; Terrier, Benjamin MD, PhD d,e ; Ayrignac, Xavier MD, PhD f ; …
Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis
F Lachenal, K Nkana… - European …, 2009 - Eur Respiratory Soc
The aim of this study was to determine the prevalence of different auto-antibodies in adult,
French cystic fibrosis (CF) patients and to look for a correlation between autoimmunity, patient …
French cystic fibrosis (CF) patients and to look for a correlation between autoimmunity, patient …
Angioimmunoblastic T-cell lymphoma
F Lachenal - Presse medicale (Paris, France: 1983), 2007 - pubmed.ncbi.nlm.nih.gov
Angioimmunoblastic T-cell lymphoma most often affects the elderly. Patients present with
generalized lymphadenopathy and systemic symptoms; half also have hepatomegaly, …
generalized lymphadenopathy and systemic symptoms; half also have hepatomegaly, …
[HTML][HTML] Dyserythropoiesis evaluated by the RED score and hepcidin: ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes
…, F Lachenal, A Toma, GM Pica, M Carre, F Garban… - …, 2019 - ncbi.nlm.nih.gov
Erythropoiesis-stimulating agents are generally the first line of treatment of anemia in patients
with lower-risk myelodysplastic syndrome. We prospectively investigated the predictive …
with lower-risk myelodysplastic syndrome. We prospectively investigated the predictive …
Profil étiologique et pronostique des valeurs extrêmes (≥ 500 mg/L) de protéine C-réactive: étude rétrospective de 168 valeurs chez 113 patients
V Hajek, F Pasquet, L Karkowski, F Lachenal… - La Revue de médecine …, 2011 - Elsevier
Propos La protéine C-réactive (CRP) est un marqueur biologique performant, de cinétique
rapide, utilisé en routine pour apprécier le syndrome inflammatoire. L’objectif de cette étude …
rapide, utilisé en routine pour apprécier le syndrome inflammatoire. L’objectif de cette étude …
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort
…, J Abraham, C Soussain, F Lachenal… - Blood …, 2024 - ashpublications.org
… The 516 present study was specifically supported by F Hoffmann-La Roche. 517 518 …
Ghesquières H, Rossi C, Cherblanc F, et al. A French multicentric prospective prognostic cohort …
Ghesquières H, Rossi C, Cherblanc F, et al. A French multicentric prospective prognostic cohort …